Choose Language
Select a language for news translation.
The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE: NVO …
Written by Eric Volkman for The Motley Fool -> This was aided in no small part by a significant analyst price target raise. That pundit maintained his buy re…
Written by Eric Volkman for The Motley Fool -> This market has a population of almost 60 million. While the drug isn't the first of its type to be sold in th…
Written by Danny Vena for The Motley Fool -> "The Odyssey" is continuing its record-breaking run. Movie-goers continue to pay up for a premium experience. T…
Michael F. Mahoney, Chairman, President & CEO of Boston Scientific Corporation (NYSE:BSX), purchased 186,240 shares of common stock at $48.34 per share on Augu…
Written by David Jagielski for The Motley Fool -> McDonald's reported comparable sales growth of just 1.3% in Q2. The business has grown modestly in recent y…
Thermo Fisher Scientific Inc. (NYSE: TMO ) and Danaher Corporation (NYSE: DHR ) are two of the world's largest life sciences tools companies, making them natur…
QXO's shares fell 23% in July after its $17 billion acquisition of TopBuild, as investors preferred cash over stock and rising oil prices and interest rates pr…
Written by Keithen Drury for The Motley Fool -> TSMC doesn't care which company wins the AI revolution, as long as it buys chips from it. Taiwan Semiconducto…
Written by Reuben Gregg Brewer for The Motley Fool -> Dividend King Procter & Gamble has an attractive 2.9% dividend yield. The company is one of the best-ru…
Written by Keith Noonan for The Motley Fool -> Gartner recorded a big earnings beat in the second quarter, and sales also beat expectations. The company rais…
